Piccart M - Search Results

1

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.

Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, Bonnefoi H, Cameron D, Gianni L, Valagussa P, Swain SM, Prowell T, Loibl S, Wickerham DL, Bogaerts J, Baselga J, Perou C, Blumenthal G, Blohmer J, Mamounas EP, Bergh J, Semiglazov V, Justice R, Eidtmann H, Paik S, Piccart M, Sridhara R, Fasching PA, Slaets L, Tang S, Gerber B, Geyer CE Jr, Pazdur R, Ditsch N, Rastogi P, Eiermann W, von Minckwitz G. Cortazar P, et al. Among authors: piccart m. Lancet. 2014 Jul 12;384(9938):164-72. doi: 10.1016/S0140-6736(13)62422-8. Epub 2014 Feb 14. Lancet. 2014. PMID: 24529560 Review.

2

Systemic treatment for locally advanced breast cancer: what we still need to learn after a decade of multimodality clinical trials.

Piccart MJ, Kerger J, Tomiak E, Perrault DJ. Piccart MJ, et al. Eur J Cancer. 1992;28(2-3):667-72. doi: 10.1016/s0959-8049(05)80122-4. Eur J Cancer. 1992. PMID: 1591090 Review.

3

Adjuvant systemic therapy for breast cancer.

Roy JA, Piccart MJ. Roy JA, et al. Among authors: piccart mj. Curr Opin Oncol. 1995 Nov;7(6):517-22. doi: 10.1097/00001622-199511000-00007. Curr Opin Oncol. 1995. PMID: 8547399 Review.

4

Adjuvant systemic therapy for breast cancer.

Piccart MJ, Biganzoli L, Roy JA. Piccart MJ, et al. Curr Opin Oncol. 1996 Nov;8(6):478-84. doi: 10.1097/00001622-199611000-00006. Curr Opin Oncol. 1996. PMID: 8971467 Review.

5

Conclusions: future strategies in the treatment of breast cancer.

Piccart MJ, Hortobagyi GN. Piccart MJ, et al. Semin Oncol. 1997 Feb;24(1 Suppl 3):S34-40. Semin Oncol. 1997. PMID: 9071339 Review.

6

Breast cancer therapies in development. A review of their pharmacology and clinical potential.

de Valeriola D, Awada A, Roy JA, Di Leo A, Biganzoli L, Piccart M. de Valeriola D, et al. Among authors: piccart m. Drugs. 1997 Sep;54(3):385-413. doi: 10.2165/00003495-199754030-00003. Drugs. 1997. PMID: 9279502 Review.

7

The contribution of molecular markers to the prediction of response in the treatment of breast cancer: a review of the literature on HER-2, p53 and BCL-2.

Hamilton A, Piccart M. Hamilton A, et al. Among authors: piccart m. Ann Oncol. 2000 Jun;11(6):647-63. doi: 10.1023/a:1008390429428. Ann Oncol. 2000. PMID: 10942052 Free article. Review.

8

State-of-the-art chemotherapy for advanced breast cancer.

Piccart MJ, Awada A. Piccart MJ, et al. Semin Oncol. 2000 Oct;27(5 Suppl 9):3-12. Semin Oncol. 2000. PMID: 11049051 Review.

9

[Breast cancer and herceptin].

Cornez N, Piccart MJ. Cornez N, et al. Among authors: piccart mj. Bull Cancer. 2000 Nov;87(11):847-58. Bull Cancer. 2000. PMID: 11125293 Free article. Review. French.

10

Proposed treatment guidelines for HER2-positive metastatic breast cancer in Europe.

Piccart MJ. Piccart MJ. Ann Oncol. 2001;12 Suppl 1:S89-94. doi: 10.1093/annonc/12.suppl_1.s89. Ann Oncol. 2001. PMID: 11521728 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

617 results

Search Page